Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Amgen biopharmaceuticals news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Biopharmaceuticals Amgen disclosed in its 2Q14 results that its board approved a plan to reduce headcount by about 12-15%, or 2,400-2,900, companywide through …

    Published on 8/4/2014
  • Aptiv Solutions, Eli Lilly, J&J, Novartis, Pfizer, Roche other news

    Aptiv Solutions, Reston, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y.…

    Published on 8/4/2014
  • BioMarin, Regeneron, Sanofi other news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN;NYSE:SNY), Paris, France Business: Other BioMarin said it sold a Priority …

    Published on 8/4/2014
  • Illumina, Genomics England, Medical Research Council, NHS England, Wellcome Trust genomics news

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Genomics England Ltd., London, U.K. Medical Research Council, London, U.K. NHS England, Redditch, U.K. Wellcome Trust, London, U.K. Business: Genomics U.K. Prime Minister …

    Published on 8/4/2014
  • Novartis other news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Other Novartis released new guidelines on investigator-initiated trials, which it defines as studies developed and sponsored by an independent investigator…

    Published on 8/4/2014
  • Reckitt Benckiser neurology news

    Reckitt Benckiser Group plc (LSE:RB), Slough, U.K. Business: Neurology Reckitt Benckiser disclosed in its 2Q14 earnings that it plans to spin out Reckitt Benckiser Pharmaceuticals Inc. its pharmaceutical business with…

    Published on 8/4/2014
  • Allergan dermatology, ophthalmic news

    Allergan Inc. (NYSE:AGN), Irvine, Calif. Business: Dermatology, Ophthalmic Allergan said it will reduce headcount by about 1,500 (13%) to about 10,200. The cuts include about 700 R&D positions and about 250 positions …

    Published on 7/28/2014
  • AstraZeneca, Eli Lilly, GlaxoSmithKline, J&J, Pfizer, Takeda, UCB, Medical Research Council pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Pfizer Inc. (…

    Published on 7/28/2014
  • Beth Israel Deaconess cancer, gene/cell therapy news

    Beth Israel Deaconess Medical Center, Boston, Mass. Business: Cancer, Gene/Cell therapy Beth Israels cancer center launched the Institute for RNA Medicine to identify non-coding RNA pathways and develop therapeutics …

    Published on 7/28/2014
  • Broad Institute neurology news

    Broad Institute of MIT and Harvard, Cambridge, Mass. Business: Neurology Philanthropist Ted Stanley committed $650 million to the Stanley Center for Psychiatric Research at the Broad Institute the largest ever funding…

    Published on 7/28/2014
  • Illumina genomics news

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Genomics Illumina disclosed in an SEC filing that Genomics England Ltd. (London, U.K.) has selected Illumina as the preferred partner for the sequencing element …

    Published on 7/28/2014
  • International Stem Cell gene/cell therapy news

    International Stem Cell Corp. (OTCBB:ISCO), Carlsbad, Calif. Business: Gene/Cell therapy Advocate General Cruz Villalon from the European Court of Justice issued an opinion arguing that an ovum whose development has …

    Published on 7/21/2014
  • Reaction Biology, NIH other news

    Reaction Biology Corp., Malvern, Pa. National Institutes of Health, Bethesda, Md. Business: Other Reaction Biology received a Phase I Small Business Innovation Research (SBIR) grant totaling $287,650 from the NIHs …

    Published on 7/21/2014
  • Shire, Sanofi, Icahn School of Medicine at Mount Sinai, Knowledge Ecology International endocrine/metabolic news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Icahn School of Medicine at Mount Sinai, New York, N.Y. Knowledge Ecology International, Washington, D.C. Business: …

    Published on 7/21/2014
  • Vertex, U.S. Centers for Medicare & Medicaid Services pulmonary news

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. U.S. Centers for Medicare & Medicaid Services (CMS), Baltimore, Md. Business: Pulmonary Three cystic fibrosis patients filed suit in the U.S. District Court for …

    Published on 7/21/2014
  • Aastrom Biosciences Inc gene/cell therapy, dermatology news

    Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy, Dermatology Aastrom will discontinue manufacturing of MACI matrix-induced autologous chondrocyte implant in Denmark. Aastrom said its…

    Published on 7/14/2014
  • Breckenridge Pharmaceutical Inc, Teva, Natco cancer news

    Breckenridge Pharmaceutical Inc., Boca Raton, Fla. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Cancer Tevas Cephalon Inc…

    Published on 7/14/2014
  • Bristol-Myers Squibb Co, Duke University pharmaceuticals news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Duke University, Durham, N.C. Business: Pharmaceuticals Bristol-Myers will provide access to information from company-sponsored trials through Dukes CRO Duke Clinical …

    Published on 7/14/2014
  • Cancer Research U cancer news

    Cancer Research UK, London, U.K. Business: Cancer Cancer Research UK announced its Programme Foundation Award, which will provide funding of up to L1.5 million ($2.6 million) over six years to mid-career scientists at U…

    Published on 7/14/2014
  • Cellular Biomedicine Group Inc gene/cell therapy news

    Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Palo Alto, Calif. Business: Gene/Cell therapy Cellular Biomedicine discontinued its consulting business segment after an internal business review and said it is now a pure-…

    Published on 7/14/2014
  • Cepheid Inc, Cubist, AstraZeneca, GlaxoSmithKline diagnostic news

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business:…

    Published on 7/14/2014
  • Cold Spring Harbor Laboratory genomics news

    Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. Business: Genomics Cold Spring Harbor received a $50 million gift from Jim and Marilyn Simons to establish the Simons Center for Quantitative Biology, which will …

    Published on 7/14/2014
  • Eli Lilly and Co, Sanofi endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Endocrine/Metabolic Sanofi filed suit in the U.S. District Court for the District of Delaware against Eli Lilly …

    Published on 7/14/2014
  • Express Scripts Holding Co supply/service news

    Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Supply/Service Express Scripts said it will begin blocking coverage this month for more than 1,000 ingredients used in compounding medications. The …

    Published on 7/14/2014
  • Pfizer Inc, Monash University pharmaceuticals news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Monash University, Victoria, Australia Business: Pharmaceuticals The university partnered with Pfizer under the pharmas Global Center for Therapeutic Innovation initiative. Pfizer …

    Published on 7/14/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993